covid-19 vaccine

Although COVID-19 treatments have improved and a vaccine is on the way, even a mild case of the virus can cause long-term complications — including the possibility of erectile dysfunction. Infectious disease expert Dr. Dena Grayson joined LX News with a warning not to let our guards down as we wait for a vaccine.

The approval comes days after the United Kingdom approved the COVID-19 vaccine.

The district will not get enough COVID-19 vaccines in the first round of distribution to cover even 10 percent of the health care workers. The federal government is allocating the doses based on population. News4’s Mark Segraves explains what this means and how it’s impacting our region.

Peter J. Pitts, a former Food and Drug Administration associate commissioner, and current president of the Center for Medicine in the Public Interest joined NBCLX and debunked many of the fears people have expressed about taking a COVID-19 vaccine.

Now that the COVID-19 vaccine is here people have questions. We have answers. Peter Pitts, a former policy advisor with the FDA, joined NBCLX to address some of the more pressing concerns many have with the possibility of receiving the vaccine for both themselves and their loved ones.

IBM security researchers say they have detected a cyberespionage effort using targeted phishing emails to try to collect vital information on the World Health Organization’s initiative for distributing COVID-19 vaccine to developing countries.

The first doses of a coronavirus vaccine given to D.C., Maryland and Virginia likely won’t be enough to immunize all the region’s health care workers. News4’s Doreen Gentzler explains.

The U.K. has become the first country to approve the Pfizer and BioNTech COVID-19 vaccine and will begin distributing doses to the public next week. Former FDA Associate Commissioner Peter Pitts says the U.S. will be right behind the U.K., predicting hundreds of millions of doses will be ready to go before Christmas.

The initial wave of vaccines likely won’t come close to covering all health care workers in D.C., Maryland and Virginia. The Centers for Disease Control and Prevention Advisory Committee on Immunization Practices voted on Tuesday to give health care personnel and residents of long-term care facilities first access to the coronavirus vaccine. The federal government plans to roll out...

We’re learning more about who will be first in line for a COVID-19 vaccine in D.C. and how many doses the city will be getting. News4’s Mark Segraves explains why DC officials say they’re only getting a fraction of what’s needed.

Two mRNA vaccines from Pfizer and Moderna are nearing final approval. But how do they work? Michael Teng, an associate professor at the University of South Florida’s College of Medicine, joined LX News to explain the role mRNA plays in making these vaccines work and why they should be trusted.

Washington, D.C., officials say they need far more initial doses of a COVID-19 vaccine than federal health officials are planning to provide.  The U.S. Department of Health and Human Services and Operation Warp Speed are planning to give 8,000 doses to D.C. in an initial distribution once a vaccine is available, D.C. Health Director Dr. LaQuandra Nesbitt said Monday....

Both Pfizer and Moderna have submitted their vaccines as part of an approval process that could take weeks.

Moderna says its COVID-19 vaccine was 94.1% effective during trials and that they will submit a request for emergency use authorization to the FDA.

Several coronavirus vaccines are now in final stages for approval, but doctors are already worried that the public won’t want to take them. Dr. Paul Biddinger, who sits on the Massachusetts governor’s advisory group for COVID-19 vaccines, joined LX News to explain the many safety steps required for the vaccines to be approved for the general public and when to...

With multiple effective vaccines on the way, Johns Hopkins’ Dr. Joshua Sharfstein says this winter season will be the “last big battle” we face against COVID-19, but that winning the fight and saving lives will require a redoubled effort by everyone.

With both the Moderna and Pfizer vaccines making headlines this week, we’re all wondering when we can sign up to get a dose. Dr. Ruth A. Karron, a research director at the Johns Hopkins Vaccine Initiative, joined LX News to explain how the vaccines are likely to get rolled out and why we all need to remain vigilant in the...

Hope could be on the horizon in the search for an effective COVID-19 vaccine thanks to countless researchers, epidemiologists, immunologists and … Dolly Parton?

Moderna and Pfizer have now both reported that their COVID-19 vaccines have been highly effective in trials. But how do they work, and what are the differences between the two? Benjamin Neuman, a professor of biological studies at Texas A&M, breaks down the specifics of both vaccines.

Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing COVID-19.